Drug recall

Platelet Pheresis, Leukocytes Reduced

FDA recall event 32038 · Class II · Central Blood Bank

Key facts

Event ID 32038
Recall numbers B-1406-5
Recalling firm Central Blood Bank
Product type Biologics
Products Platelet Pheresis, Leukocytes Reduced
Classification Class II
Status Terminated
Voluntary or mandated Firm Initiated
Reason for recall Blood products, which were possibly contaminated with Staphylococcus species, were distributed.
Initiation date Mar 3, 2005
Termination date Jul 1, 2005
City Pittsburgh
Country United States
FEI number 2571073

At a glance

  • 1–9 Products in this recall
  • 10–99 FDA inspections of this firm (FEI)

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA drug and product recalls

FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.

Source: U.S. Food and Drug Administration (FDA), Enforcement Reports

Browse all FDA drug and product recalls